• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A patient with Factor V Leiden and a related pulmonary embolism.

作者信息

Downs Janet, Childers William A

机构信息

Janet Downs practices emergency medicine at Genesis Healthcare in Zanesville, Ohio. William A. Childers, Jr., is director of the PA program at West Liberty (W.Va.) University. The authors have disclosed no potential conflicts of interest, financial or otherwise.

出版信息

JAAPA. 2016 Feb;29(2):34-5. doi: 10.1097/01.JAA.0000473362.92597.d8.

DOI:10.1097/01.JAA.0000473362.92597.d8
PMID:26818643
Abstract

Venous thromboembolism (VTE) is a complication associated with the hypercoaguable state produced in patients with Factor V Leiden deficiency. Clinically, patients can present with pleuritic chest pain, dyspnea, tachycardia, and unilateral leg swelling, warmth, erythema, and pain. Treatment with heparin is urgent, and patients should continue an anticoagulation drug regimen at home.

摘要

相似文献

1
A patient with Factor V Leiden and a related pulmonary embolism.
JAAPA. 2016 Feb;29(2):34-5. doi: 10.1097/01.JAA.0000473362.92597.d8.
2
Is the prevalence of the factor V Leiden mutation in patients with pulmonary embolism and deep vein thrombosis really different?肺栓塞和深静脉血栓形成患者中因子V莱顿突变的患病率真的不同吗？
Thromb Haemost. 1999 Mar;81(3):345-8.
3
[Venous and arterial thromboembolism in a patient with factor V R506Q Leiden mutation and heparin-induced immuno-allergic reaction].
Rev Med Liege. 2001 Jul;56(7):493-6.
4
High frequency of factor V Leiden in surgical patients with symptomatic venous thromboembolism despite prophylaxis.尽管采取了预防措施，但有症状静脉血栓栓塞的外科手术患者中因子V莱顿突变的高发生率。
Thromb Haemost. 2007 Feb;97(2):171-5.
5
Factor V Leiden: how great is the risk of venous thromboembolism?莱顿因子 V：静脉血栓栓塞风险有多大？
Cleve Clin J Med. 2012 Apr;79(4):265-72. doi: 10.3949/ccjm.79a.11072.
6
Risk factor profiles in patients with different clinical manifestations of venous thromboembolism: a focus on the factor V Leiden mutation.静脉血栓栓塞不同临床表现患者的危险因素概况：聚焦于凝血因子V莱顿突变
Thromb Haemost. 1996 Oct;76(4):510-3.
7
Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.凝血因子V莱顿突变与凝血酶原20210A联合作用对静脉血栓栓塞风险的影响——对8项病例对照研究的汇总分析，包括2310例病例和3204例对照。静脉血栓栓塞汇总分析研究组
Thromb Haemost. 2001 Sep;86(3):809-16.
8
Factor V leiden homozygosity, dyspnea, and reduced pulmonary function.凝血因子V莱顿纯合子、呼吸困难与肺功能减退
Arch Intern Med. 2005 Sep 26;165(17):2032-6. doi: 10.1001/archinte.165.17.2032.
9
The risk of recurrent venous thromboembolism in patients with and without factor V Leiden.伴有和不伴有凝血因子V莱顿突变的患者复发性静脉血栓栓塞的风险。
Thromb Haemost. 1997 Apr;77(4):624-8.
10
Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery.凝血因子V莱顿突变（G1691A）和凝血酶原基因G20210A突变作为全髋关节或全膝关节置换术后静脉血栓栓塞的潜在危险因素。
Thromb Haemost. 2002 Apr;87(4):580-5.

引用本文的文献

1
Massive Pulmonary Embolism Associated With Factor V Leiden Mutation in a Young Female on Oral Contraceptive Pills: A Case Report.口服避孕药的年轻女性中与因子V莱顿突变相关的大面积肺栓塞：病例报告
Cureus. 2024 Jun 15;16(6):e62451. doi: 10.7759/cureus.62451. eCollection 2024 Jun.